Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01391793 · ClinicalTrials.gov registry record · Phase 3
Corticosteroids for Children With Febrile Urinary Tract Infections
A Phase 3 study of Urinary Tract Infection and Acute Urinary Tract Infection, sponsored by Nader Shaikh.
- Completed
- Registry status
- Phase 3
- Development phase
- 546
- Enrollment target
- 6
- Study locations
NCT01391793 is a Phase 3 study of Urinary Tract Infection and Acute Urinary Tract Infection that has completed, run by Nader Shaikh. The registered enrollment target is 546 participants, below the 624-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (12% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT01391793, a Phase 3 study of Urinary Tract Infection and Acute Urinary Tract Infection, has completed, sponsored by Nader Shaikh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 546 participants
- Enrollment target
- 6
- Study locations
Study Summary
In this study the investigators will determine whether corticosteroids given at the time of urinary tract infection help prevent permanent damage to the kidneys.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dexamethasone
Study Locations (6)
District of Columbia
- Children's National Medical Center - Washington D.C.
Ohio
- Nationwide Children's Hospital in Columbus - Columbus
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Rhode Island
- Hasbro Children's Hospital - Providence
Utah
- Primary Children's Hospital - Salt Lake City
Wisconsin
- American Family Children's Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-03-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01391793
The ClinicalTrials.gov registry entry for NCT01391793 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 624-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (12% lower). The listed sponsor is Nader Shaikh, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01391793 reports 6 study locations spanning 6 distinct geographic areas - top geographies include District of Columbia, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01391793 about?
NCT01391793 is a clinical study titled "Corticosteroids for Children With Febrile Urinary Tract Infections". In this study the investigators will determine whether corticosteroids given at the time of urinary tract infection help prevent permanent damage to the kidneys.
What is the current status of trial NCT01391793?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 546 participants. The study started on 2011-09. Estimated completion is 2018-03-30.
What conditions does trial NCT01391793 study?
This clinical trial studies the following conditions: Urinary Tract Infection, Acute Urinary Tract Infection.
What interventions are being tested in trial NCT01391793?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT01391793?
This trial is sponsored by Nader Shaikh, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01391793 being conducted?
This trial has 6 study locations across District of Columbia, Ohio, Pennsylvania, Rhode Island, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
COMPLETED · Phase 3
-
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
RECRUITING · NA
-
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
RECRUITING · NA
-
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
COMPLETED · NA
-
ParentLink: Better and Safer Emergency Care for Children
COMPLETED
-
Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
COMPLETED · Phase 4
Explore more on PlainTrial
Urinary Tract Infection
All registered trials for this condition
Acute Urinary Tract Infection
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.